B. Fisher

Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

James J. Rusthoven, Elizabeth A. Eisenhauer, Charles Butts et al. · Journal of Clinical Oncology · 1999 · 218 citations

Randomized Phase II Study of Two Doses of Gefitinib in Hormone-Refractory Prostate Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group

Christina M. Canil, Malcolm J. Moore, Eric Winquist et al. · Journal of Clinical Oncology · 2005 · 207 citations

Phase II study of Triapine® in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161)

Jennifer J. Knox, Sébastien J. Hotte, Christian Kollmannsberger et al. · Investigational New Drugs · 2007 · 150 citations

National Cancer Institute, Urology, Genitourinary Cancer +7

A quantitative approach to radiography of the lower limb. Principles and applications

TD Cooke, R. Allan Scudamore, J. Timothy Bryant et al. · Journal of Bone and Joint Surgery - British Volume · 1991 · 147 citations

Lower Limb Trauma, Surgery, Anatomy +21

Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma

Frances A. Shepherd, Janet Dancey, Andrew Arnold et al. · Cancer · 2001 · 145 citations · Full text